GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GeneDx Holdings WGS · USD

Health Care · US listing · 🇺🇸 United States

Compare

65.72

+5.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$427.5m

FY2018FY2025

Net income

−$21.0m

FY2018FY2025

Free cash flow

$14.3m

FY2018FY2025

Shareholders' equity

$308.2m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$427.5m$305.4m$202.6m$234.7m$212.2m$179.3m$196.2m$133.3m
Gross profit$298.2m$194.4m$90.0m−$26.8m−$16.6m$4.0m$82.8m$41.2m
Research and development$72.0m$45.7m$58.3m$86.2m$105.2m$72.7m$34.9m$20.7m
Operating income−$18.6m−$49.6m−$180.6m−$667.7m−$446.1m−$242.0m−$30.4m−$28.7m
Net income−$21.0m−$52.3m−$175.8m−$549.0m−$245.4m−$241.3m−$29.7m−$26.8m
Diluted earnings per share-0.78-1.94-6.77-46.63-33.53-42.89-5.28-3.72

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$570.2m$419.4m$418.8m$545.3m$554.1m$251.6m——
Cash and short-term investments$171.3m$141.2m$130.1m$137.4m$400.6m$108.1m——
Total liabilities$262.0m$174.1m$190.7m$291.6m$166.0m$247.3m——
Debt$57.1m$72.1m$73.0m$25.5m$32.8m$45.0m$25.0m—
Shareholders' equity$308.2m$245.2m$228.0m$253.7m$388.1m$4.4m——
Shares outstanding27m27m26m12m7m6m6m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations$33.3m−$28.5m−$180.1m−$319.2m−$190.4m−$93.1m−$18.7m−$24.7m
Capital spending−$19.0m−$5.5m−$5.7m−$14.3m−$20.8m−$32.0m−$15.5m−$3.9m
Free cash flow$14.3m−$34.0m−$185.9m−$333.5m−$211.2m−$125.1m−$34.2m−$28.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$114.4m$102.3m$121.0m$116.7m$102.7m$87.1m$95.6m$76.9m
Gross profit$78.2m$68.2m$78.9m$84.5m$70.9m$58.5m$66.2m$47.8m
Operating income−$17.1m−$61.7m−$17.7m−$6.8m$9.0m−$5.4m$8.8m−$7.5m
Net income−$17.7m−$63.3m−$17.7m−$7.6m$10.8m−$6.5m$5.4m−$8.3m
Diluted earnings per share-0.60-2.13-0.66-0.280.40-0.240.20-0.31
Cash from operations−$28.0m−$32.0m−$3.0m$15.0m$10.0m$10.0m−$3.0m−$4.0m
Capital spending−$10.0m−$6.0m−$4.0m−$6.0m−$2.0m−$6.0m−$3.0m—
Free cash flow−$38.0m−$38.0m−$7.0m$9.0m$8.0m$4.0m−$6.0m—
Total assets$481.5m$506.3m$570.2m$493.9m$463.9m$446.4m$419.4m$408.8m
Cash and short-term investments$132.5m$170.7m$171.3m$155.1m$134.6m$159.2m$141.2m$116.5m
Debt$102.5m$101.9m$57.1m$56.0m$54.8m$54.9m$55.2m$55.7m
Shareholders' equity$244.2m$254.1m$308.2m$292.3m$277.1m$257.4m$245.2m$204.5m

Financial ratios

Data as of 26 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin69.7%63.6%44.4%-11.4%-7.8%2.2%—
Operating margin-4.4%-16.2%-84.0%-194.9%-114.3%-133.2%—
Net margin-4.9%-17.1%-86.8%-233.9%-115.6%-134.6%—
Return on equity-6.8%-21.3%-77.1%-216.4%-63.2%-5500.0%—
Return on assets-3.7%-12.5%-42.0%-100.7%-44.3%-95.9%—
Free cash flow yield3.5%-1.5%-12.0%-46.1%-41.3%-19.4%—
Revenue growth40.0%50.8%-13.7%10.6%18.3%-8.6%—
Earnings growth-59.8%-70.3%-68.0%123.7%1.7%712.5%—
Current ratio2.46x3.61x3.10x1.47x4.77x2.37x—
Debt to equity0.19x0.23x0.25x0.07x0.04x5.12x—
Equity ratio54.0%58.5%54.5%46.5%70.0%1.7%—
Interest coverage-7.32x-16.36x—-142.66x-85.56x-96.55x-36.94x
R&D as a share of sales16.8%15.0%28.8%36.7%49.6%40.5%—
Buybacks as a share of market value0.4%-3.9%-120.7%-60.9%-30.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue22.1%19.0%—
Operating income-69.7%-40.1%—
Net income-66.3%-38.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.2%47.5%34.8%—
Operating margin-9.3%-78.3%-102.7%—
Net margin-10.0%-68.2%-82.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-84.5-11.5-0.1-0.1-1.3-2.5
Price to sales4.22.00.10.11.53.3

Market value over time

30 Nov 2020 to 23 Oct 2026, in USD

$2.03bn$1.67bn

Share price return

Finished calendar years

202520242023202220212020
Return210%3445%-73%-95%-60%15%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 33-to-1 reverse split · 4 May 2023
  • 1-to-1 reverse split · 23 Jul 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.